Cleancore Solutions, Inc. (ZONE) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on June 8, 2026, by Cleancore Solutions, Inc., a Nevada corporation. The filing reports the entry into a new material definitive agreement for equity financing and the termination of a prior sales agreement. The Company is an emerging growth company listed on NYSE American LLC.
Key Financial Metrics and Agreements
- New Equity Facility: Entered into a Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. and Curvature Securities LLC to sell up to $750,000,000 of common stock.
- Commission Structure: The Company will pay the new agents a cash commission of up to 3.0% of gross proceeds.
- Termination Costs: To terminate the prior agreement with Maxim Group LLC and Curvature, the Company agreed to pay $1,000,000 to Maxim and $500,000 to Curvature.
- Warrant Adjustments:
- Maxim Partners LLC warrant exercise price reduced from $1.33 to $0.90 per share (3,150,008 shares).
- Curvature and affiliates warrant exercise price reduced from $1.33 to $1.18 per share (2,100,005 shares).
- Future Fees: Curvature will receive a fee of 0.20% of gross proceeds from future at-the-market sales for two years, with the $500,000 cash payment credited against this fee.
Material Changes and Use of Proceeds
The primary material change is the replacement of the prior "at-the-market" sales agreement (effective August 29, 2025) with a new facility allowing for up to $750 million in sales. The Company intends to use net proceeds for:
- AI Critical Infrastructure Business: Site identification, land acquisition, engineering, power procurement, permitting, facility construction/retrofit, and equipment acquisition.
- General Corporate Purposes: Working capital, capital expenditures, and general and administrative expenses.
- Strategic Transitions: Funding costs associated with the potential disposition of the cleaning products business or the wind-down of the digital asset treasury strategy.
Guidance, Risks, and Contingencies
The filing does not provide specific financial guidance or revenue projections. Key contingencies and risks include:
- Discretionary Sales: The Company has no obligation to sell any shares and may suspend or terminate the agreement at any time.
- Termination Rights: Either party may terminate the agreement with ten (10) business days' prior written notice. Agents may also terminate upon a material adverse effect.
- Business Pivot: The Company is actively considering the disposition of its cleaning products business and the wind-down of its digital asset strategy, indicating a significant strategic shift.
Investor Verification Checklist
- Verify the current market price of ZONE stock relative to the new warrant exercise prices ($0.90 and $1.18) to assess immediate dilution potential.
- Confirm the status of the "cleaning products business" disposition and "digital asset treasury strategy" wind-down to understand the timeline for the strategic pivot.
- Review the full text of the Sales Agreement (Exhibit 1.1) for specific conditions regarding "material adverse effect" that could halt sales.
- Monitor future filings for actual share issuances under the new $750 million facility to gauge capital raising velocity.